Several studies have illustrated that EGFR mutations are significantly associated with longer OS in NSCLC patients with brain metastases [14–19], yet numerous other studies show no association between EGFR mutations and OS for these patients [20–29]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.